AGP Picks
View all

Tech Times of New York
Provided by AGP

Tech Times of New York: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Times of New York.

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

Press releases published on May 22, 2026

Greenwich LifeSciences Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q Filing
May 22, 2026

Greenwich LifeSciences Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q Filing

Indeterminate GlobeNewswire
Alerus Financial Corporation Declares Cash Dividend on Common Shares
May 22, 2026

Alerus Financial Corporation Declares Cash Dividend on Common Shares

Indeterminate GlobeNewswire
SUPER MICRO DEADLINE TUESDAY: Super Micro Computer, Inc. Investors Have Until May 26th to Contact Bragar Eagel & Squire, P.C. To Seek Lead Plaintiff Role
May 22, 2026

SUPER MICRO DEADLINE TUESDAY: Super Micro Computer, Inc. Investors Have Until May 26th to Contact Bragar Eagel & Squire, P.C. To Seek Lead Plaintiff Role

Indeterminate GlobeNewswire
SCYNEXIS Announces One-for-Eight Reverse Stock Split
May 22, 2026

SCYNEXIS Announces One-for-Eight Reverse Stock Split

Indeterminate GlobeNewswire
NANOBIOTIX Announces Full Exercise of Underwriters’ Over-Allotment Option, Bringing Gross Proceeds of Offering to Approximately $100 Million
May 22, 2026

NANOBIOTIX Announces Full Exercise of Underwriters’ Over-Allotment Option, Bringing Gross Proceeds of Offering to Approximately $100 Million

Indeterminate GlobeNewswire
NANOBIOTIX annonce l’exercice integral de l’option de surallocation, portant le produit de l'offre a 100 millions de dollars
May 22, 2026

NANOBIOTIX annonce l’exercice integral de l’option de surallocation, portant le produit de l'offre a 100 millions de dollars

Indeterminate GlobeNewswire
Maris-Tech Announces Receipt of Nasdaq Notification of Minimum Stockholders’ Equity Non-Compliance
May 22, 2026

Maris-Tech Announces Receipt of Nasdaq Notification of Minimum Stockholders’ Equity Non-Compliance

Indeterminate GlobeNewswire
Orange County Bancorp, Inc. Declares Cash Dividend
May 22, 2026

Orange County Bancorp, Inc. Declares Cash Dividend

Indeterminate GlobeNewswire
XTL Announces Receipt of Staff Delist Determination from Nasdaq
May 22, 2026

XTL Announces Receipt of Staff Delist Determination from Nasdaq

Indeterminate GlobeNewswire
Mission Produce and Calavo Growers Merger Obtains Mexican Antitrust Approval
May 22, 2026

Mission Produce and Calavo Growers Merger Obtains Mexican Antitrust Approval

Indeterminate GlobeNewswire
IMMUNITYBIO CLASS ACTION DEADLINE TUESDAY MAY 26th: Bragar Eagel & Squire, P.C. Urges Immunity Bio, Inc. Stockholders with Significant Losses to Contact the Firm Regarding Their Rights Before May 26th
May 22, 2026

IMMUNITYBIO CLASS ACTION DEADLINE TUESDAY MAY 26th: Bragar Eagel & Squire, P.C. Urges Immunity Bio, Inc. Stockholders with Significant Losses to Contact the Firm Regarding Their Rights Before May 26th

Indeterminate GlobeNewswire
Abivax Presents First Quarter 2026 Financial Results and Reports Three-Year Interim Data from Study 108, a Phase 2a/2b Open-Label Extension Trial of Obefazimod Following Dose De-Escalation in Patients with Ulcerative Colitis
May 22, 2026

Abivax Presents First Quarter 2026 Financial Results and Reports Three-Year Interim Data from Study 108, a Phase 2a/2b Open-Label Extension Trial of Obefazimod Following Dose De-Escalation in Patients with Ulcerative Colitis

Indeterminate GlobeNewswire
Abivax présente ses résultats financiers du T1 2026 et les données à trois ans de l’étude 108, un essai d’extension ouvert de phase 2a/2b évaluant l’obéfazimod après réduction de dose dans la RCH
May 22, 2026

Abivax présente ses résultats financiers du T1 2026 et les données à trois ans de l’étude 108, un essai d’extension ouvert de phase 2a/2b évaluant l’obéfazimod après réduction de dose dans la RCH

Indeterminate GlobeNewswire
Crinetics Pharmaceuticals to Participate in Jefferies Global Healthcare Conference 2026
May 22, 2026

Crinetics Pharmaceuticals to Participate in Jefferies Global Healthcare Conference 2026

Indeterminate GlobeNewswire
E-Power Inc. Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
May 22, 2026

E-Power Inc. Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

Indeterminate GlobeNewswire
Avalo Therapeutics Announces Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
May 22, 2026

Avalo Therapeutics Announces Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
All In FutureTech Alliance Long-Term Strategic Direction Following the HyalRoute Acquisition: Building a Future Technology Platform Driven by AI Infrastructure and AI Applications, with Optical Technologies at Its Core
May 22, 2026

All In FutureTech Alliance Long-Term Strategic Direction Following the HyalRoute Acquisition: Building a Future Technology Platform Driven by AI Infrastructure and AI Applications, with Optical Technologies at Its Core

Indeterminate GlobeNewswire
Qinux Vultriox Trimmer Unveiled 2026 Advanced Grooming Solution for Qinux Vultriox Modern Styling Everyone Talking About
May 22, 2026

Qinux Vultriox Trimmer Unveiled 2026 Advanced Grooming Solution for Qinux Vultriox Modern Styling Everyone Talking About

Indeterminate GlobeNewswire
Neuro Salt Consumer Report 2026 The Nerve Health Support Supplement Taking Of Neuro Salt for neuropathy Natural Wellness
May 22, 2026

Neuro Salt Consumer Report 2026 The Nerve Health Support Supplement Taking Of Neuro Salt for neuropathy Natural Wellness

Indeterminate GlobeNewswire
JellyThin Gummies Exploding in 2026: Jelly Thin ACV Keto Gummies Shocking Weight Loss Trend Promising Simplicity in an Age of Wellness Overload
May 22, 2026

JellyThin Gummies Exploding in 2026: Jelly Thin ACV Keto Gummies Shocking Weight Loss Trend Promising Simplicity in an Age of Wellness Overload

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Tech Times of New York

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.